BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31157674)

  • 1. Treatment of substance use disorders with co-occurring severe mental health disorders.
    Murthy P; Mahadevan J; Chand PK
    Curr Opin Psychiatry; 2019 Jul; 32(4):293-299. PubMed ID: 31157674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of dual diagnosis disorders.
    Murthy P; Chand P
    Curr Opin Psychiatry; 2012 May; 25(3):194-200. PubMed ID: 22395768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of comorbid bipolar disorder and substance use disorders.
    Salloum IM; Brown ES
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):366-376. PubMed ID: 28301219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of schizophrenia with substance use disorders.
    Lybrand J; Caroff S
    Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of comorbid bipolar disorder and substance abuse.
    Vornik LA; Brown ES
    J Clin Psychiatry; 2006; 67 Suppl 7():24-30. PubMed ID: 16961421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of substance use disorders in schizophrenia.
    Bennett ME; Bradshaw KR; Catalano LT
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):377-390. PubMed ID: 27715317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial approaches to dual diagnosis.
    Drake RE; Mueser KT
    Schizophr Bull; 2000; 26(1):105-18. PubMed ID: 10755672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.
    Ziedonis DM; Smelson D; Rosenthal RN; Batki SL; Green AI; Henry RJ; Montoya I; Parks J; Weiss RD
    J Psychiatr Pract; 2005 Sep; 11(5):315-39. PubMed ID: 16184072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of psychotherapy on comorbid bipolar disorder and substance use disorder: A systematic review.
    Crowe M; Eggleston K; Douglas K; Porter RJ
    Bipolar Disord; 2021 Mar; 23(2):141-151. PubMed ID: 32615028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use.
    Adan A; Marquez-Arrico JE; Gilchrist G
    Health Qual Life Outcomes; 2017 Oct; 15(1):209. PubMed ID: 29061151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating comorbid substance use disorders in schizophrenia.
    Lubman DI; King JA; Castle DJ
    Int Rev Psychiatry; 2010; 22(2):191-201. PubMed ID: 20504059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions.
    Painter JM; Malte CA; Rubinsky AD; Campellone TR; Gilmore AK; Baer JS; Hawkins EJ
    Am J Drug Alcohol Abuse; 2018; 44(3):386-394. PubMed ID: 29095057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
    Arranz B; Garriga M; García-Rizo C; San L
    Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of substance abusing patients with comorbid psychiatric disorders.
    Kelly TM; Daley DC; Douaihy AB
    Addict Behav; 2012 Jan; 37(1):11-24. PubMed ID: 21981788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Blanco C; Alegría AA; Liu SM; Secades-Villa R; Sugaya L; Davies C; Nunes EV
    J Clin Psychiatry; 2012 Jun; 73(6):865-73. PubMed ID: 22480900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bipolar patient with comorbid substance use disorder: recognition and management.
    Albanese MJ; Pies R
    CNS Drugs; 2004; 18(9):585-96. PubMed ID: 15222775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between alcohol and substance use disorders and psychiatric service use in patients with severe mental illness: a nationwide Danish register-based cohort study.
    Jørgensen KB; Nordentoft M; Hjorthøj C
    Psychol Med; 2018 Nov; 48(15):2592-2600. PubMed ID: 29429425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in service utilization among Operations Enduring Freedom, Iraqi Freedom, and New Dawn Veterans Affairs patients with severe mental illness and substance use disorders.
    Painter JM; Brignone E; Gilmore AK; Lehavot K; Fargo J; Suo Y; Simpson T; Carter ME; Blais RK; Gundlapalli AV
    Psychol Serv; 2018 Feb; 15(1):11-20. PubMed ID: 28517950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
    Green AI
    J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapies for co-occurring substance use and bipolar disorders: A systematic review.
    Coles AS; Sasiadek J; George TP
    Bipolar Disord; 2019 Nov; 21(7):595-610. PubMed ID: 31077521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.